High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP4779
JournalEuropean Heart Journal
Volume40
Issue numberSupplement 1
Pages (from-to)2983
Number of pages1
ISSN0195-668X
DOIs
Publication statusPublished - 2019

ID: 235340488